Because the FDA removed semaglutide and tirzepatide from shortage in 2025, compounded versions now move through the personalization pathway, meaning a clinician documents a specific clinical reason, rather than mass copying of the brand drug
Engaging with a healthcare provider who considers individual challengessuch as cultural dietary habits, work-related fatigue, or family responsibilitiesmay support more sustainable weight loss outcomes
Obesity 28 , 529536 (2020)
In contrast with other GLP-1 agonists, maternal exposure to exendin-4 resulted in an increase in pre-weaning fetal growth in one study (15)
Personalized Care for Your Best Results Choosing the right medication is a personal decision that depends on your health profile, preferences, and goals
[253 254 255 256 257 258] Other commenters recommended Functional Communication Measures (FCMs) for swallowing to ensure adequate nutrition, hydration, and recovery